When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MyoKardia (NASDAQ:MYOK) announces that its four-year collaboration with Sanofi (NYSE:SNY) aimed at hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) ended on December 31, 2018. The partnership will formally conclude on April 1 with MYOK regaining global rights to its product portfolio, including mavacamten and MYK-491.
More news on: MyoKardia, Sanofi, Healthcare stocks news,